Delivery Order SPE2DB22D3301-SPE2DB24FZ0PG
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,759.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the government. The contract has a completion date of May 7, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This federal contract award, valued at $1,678.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,843.24 firm fixed-price delivery order is for the pharmaceutical product VIMPAT 200 MG TABLET 60S. The award has an ultimate completion date of February 11, 2025. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The award has a potential value of $1,487.60 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
This federal contract award, valued at $2,683.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of March 29, 2024. This award is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug...
This federal contract award was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,592.94, is for the delivery of 60 count tablets of the pharmaceutical product VIMPAT 200 mg. This is a firm fixed price delivery order contract with a completion date of June 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,023.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 4,565,044,252 units of the pharmaceutical product VIMPAT 200 MG TABLET 60S. The contract has a period of performance through July 2, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,353.53 firm-fixed-price delivery order is for the supply of VIMPAT 200 mg tablets, with a period of performance through May 31, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for $1,313.04 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed-price delivery order for the pharmaceutical product VIMPAT 100 MG TABLET UD 60S, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no set-aside designation. This award is part of a larger indefinite delivery contract (IDC) valued up to...